Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 19, 2022
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
Chao Zhu, Zhen Zhou, Izanne Roos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 30, 2022
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Sifat Sharmin, Charles B Malpas, Izanne Roos, et al.
Journal of Neurology
|
April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study
Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Neurology
|
November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD
Pakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
CNS Drugs
|
February 14, 2025
Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study
Jannis Müller, Sifat Sharmin, Johannes Lorscheider, et al.
Brain : a Journal of Neurology
|
June 10, 2026
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis
Carmen Tur, Silvia Susin-Calle, Susana Otero-Romero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 28, 2025
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years
Jodie I Roberts, Sifat Sharmin, Dana Horakova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 20, 2025
Managing reactivation of multiple sclerosis during treatment with natalizumab
Nathaniel Lizak, Sifat Sharmin, Dana Horáková, et al.
Neurology
|
March 5, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder
Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt, et al.
JAMA Neurology
|
June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Stella Hughes, Gavin McDonnell, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 19, 2022
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
Chao Zhu, Zhen Zhou, Izanne Roos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 30, 2022
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Sifat Sharmin, Charles B Malpas, Izanne Roos, et al.
Journal of Neurology
|
April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study
Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Neurology
|
November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD
Pakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
CNS Drugs
|
February 14, 2025
Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study
Jannis Müller, Sifat Sharmin, Johannes Lorscheider, et al.
Brain : a Journal of Neurology
|
June 10, 2026
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis
Carmen Tur, Silvia Susin-Calle, Susana Otero-Romero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 28, 2025
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years
Jodie I Roberts, Sifat Sharmin, Dana Horakova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 20, 2025
Managing reactivation of multiple sclerosis during treatment with natalizumab
Nathaniel Lizak, Sifat Sharmin, Dana Horáková, et al.
Neurology
|
March 5, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder
Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt, et al.
JAMA Neurology
|
June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Stella Hughes, Gavin McDonnell, et al.
Page
of 8